Single Center Post-Market Study of Thrombolytic Therapy Using the Versus™ Catheter

RecruitingOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

September 5, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Blood ClotsVascular DiseaseEmbolism ThrombosisCardiovascular DiseasesLung Diseases
Interventions
DEVICE

Versus™ Endovascular Pulmonary Artery Drug Delivery Catheter

The Versus Pulmonary Artery Catheter is a dual-tip, infusion catheter. Two lumens access and deliver physician-specified fluids, including thrombolytics, into the pulmonary arteries of each lung via a single access site. The Secondary Catheter tip telescopes independently to facilitate infusion into the contralateral lung. The device may allow for assessment of a patient's hemodynamic condition through direct intracardiac and pulmonary artery pressure monitoring. Pressure is measured through an interface between the catheter's fluid lumen and an externally located, FDA-cleared, pressure transducer. The device may include an additional lumen that is in communication with a distal flow-directed balloon.

Trial Locations (1)

22903

RECRUITING

University of Virginia Medical Center, Charlottesville

Sponsors
All Listed Sponsors
lead

Liquet Medical Inc.

INDUSTRY